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Abstract. Complete inactivation of the human retino-
blastoma gene is believed to be an essential step in 
tumorigenesis of several different cancers. Using the plasmid 
pRbCAT2 that contains the Rb promoter region was tested 
for its ability to promote transcription of the bacterial 
chloramphenicol acetyltransferase (CAT) gene in a transient 
expression assay. This plasmid was co-transfected in a short 
term transfections with the plasmids pH06Tl and pHOóNl 
that contains the mutant and normal Η-ras gene respectively, 
into the human cell line HeLa, by the calcium phosphate 
technique. It was found that the mutant Η-ras gene enhances 
the activity of the Rb gene promoter in contrast to the normal 
Η-ras gene that inhibits it. The expression of the CAT gene 
in stable clones of HeLa cells carrying the promoter of Rb 
gene after treatment with TPA and EGF respectively, was 
also investigated, whereas TPA enhanced, EGF had no effect 
on the activity of the Rb gene promoter. 
Introduction 
The Rb gene was the first human tumor suppressor gene 
isolated and is located on the long arm of human 
chromosome 13 (1-3). This gene contains 27 exons dispersed 
within 200 Kb of genomic DNA (4) and expresses a 4.7 Kb 
mRNA transcript in all normal tissues (2). Negative 
regulation of the cell cycle by Rb-1 was implied from the 
model proposed by Kundson (5) who predicted that 
retinoblastoma arose after the mutation of both alleles of Rb-1. 
The product encoded by Rb gene is a nuclear protein found 
in phosphorylated and unphosphorylated states (6). The pi 10 
is complexed by large Τ antigen (7), E7 (8) and Eia (9) 
transforming proteins of SV40, adenovirus and human 
papilloma virus, respectively. 
Cancer cells become tumorigenic as a result of multiple 
independent steps (for review see ref. 10) which subvert the 
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normal growth control mechanisms. Some of these steps 
have been linked with mutations that either activate proto-
oncogenes such as ras and myc, or remove the inhibitory 
action of tumor-suppressor genes such as Rb and p53. In 
spite of their importance in the mechanism of carcinogenesis, 
little is known about the normal functions of ras and Rb. 
The members of the ras family, Harvey (H), Kirsten (Κ) 
and N-ras genes, code for GTP binding proteins of 21,000 
daltons (ras p21). Ras p21 shares sequence homology with G 
proteins which are known to be signal transducers and they 
are associated with the inner surface of the plasma membrane 
and exhibit GTPase activity (11). The product of the different 
ras genes are thought to play a role in transduction of 
external signals towards an intracellular target. These 
proteins bind GTP and posses an intrinsic GTPase activity 
implicated in the regulation of their activity (12). A model 
has been suggested (13) where p21 mediates a signal to 
intracellular targets after it has received another signal from a 
growth factor through its receptor. It is interesting to note in 
this connection that EGF, which has the same receptor as a 
TGF, stimulates p21 to bind GTP (14). 
Phorbol esters such as TPA ( 12-O-tetradecanoylphorbol-
13-acetate) are tumor promoters which are capable of 
potentiating the effect of an initiating carcinogen. It is 
thought that they exert their biological effect by altering gene 
expression through a process which involves the activation of 
protein kinase C (15). Relevant to this hypothesis is the 
finding that TPA induces transcription of cellular proto-
oncogenes, e.g. c-fos (16,17), c-myc (16,18) and c-sis (19). In 
an attempt to identify the target of transcription regulation by 
ras, we examined its effect on the promoter of the Rb gene, 
in expectation of activation of Rb transcription by ras. We 
also tested whether the Rb promoter could be activated by 
TPA and EGF. Our results show that mutant Η-ras gene 
enhances the activity of the Rb gene promoter in contrast to 
the normal Η-ras gene that inhibits it. TPA, was able to 
induce expression of a CAT gene linked to the human Rb 
promoter region, whereas EGF had no effect on the activity 
of the Rb gene promoter. 
Materials and methods 
Cells and plasmids. pRbCAT2 contains human Rb-1 
promoter sequence between -1546 and +186 (relative to the 
major start site of transcription) linked to the chlor-
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Figure 1. Plasmid pRbCAT2-A was constructed by ligation of the 1.9 Kb 
BamHI fragment of the aph gene into BamHI-digested plasmid pRbCAT2. 
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Figure 2. Effect of human H-ras on Rb transcription. pRbCAT2 (lanes 1-3) 
was cotransfected with pHomer 6 (lane 1). pH06Nl (lane 2) and pH06Tl 
(lane 3) into HeLa cells. Plasmids p+53ACAT (lane 4) and p201 (lane 5), 
negative and positive control, respectively, were transfected into HeLa cells. 
amphenicol acetyltransferase (CAT) gene (2). Plasmid 
P+53ACAT is the 5' deletion constract of pRbCAT2 (20). 
Plasmid p201 carry the aph gene and the CAT gene linked to 
the human mutant T24 Η-ras promoter region (21). Plasmids 
pHOöTl and pH06Nl contains the 6.6 Kb of the mutant and 
normal Η-ras gene, respectively (22). Plasmid pRbCAT2-A 
carry the human Rb-1 promoter sequence between -1546 and 
+ 186 and linked to the CAT gene, the 1.9 Kb Bam HI 
fragment of the aph gene (Fig 1). 
HeLa cells (ATCC CCL 2) were cultured in Dulbecco's-
F12 medium supplemented with 10% fetal calf serum. 
DNA transection and CAT assays. Transfections of HeLa 
cells with plasmid DNA were performed using a 
modification (23) of the calcium phosphate technique (24). 
Stable transfectants were isolated in the presence of 200 
μg/ml geneticin. For CAT assays, cells were grown 
exponentially in absence of geneticin. TPA was purchased 
from Sigma and lOOOx stocks were made in DMSO. EGF 
was purchased from Collaborative Research Incorporation 
and 50 ng/ml stock was made in Dulbecco's-F12 medium. 
Cells in the presence or absence of TPA or EGF were 
harvested and assayed for CAT activity as previously 
described (25). HeLa cells were cotransfected by the calcium 
phosphate precipitation technique with 10 μg of reporter 
constract and 30 μg of each effector constract (pH06Tl, 
pH06Nl and pHomer 6). All CAT assays were repeated at 
least twice and the reproducibility of the results was 
confirmed. 
Results 
Suppression of Rb transcription by the normal Η-ras protein. 
In transient-expression assays using HeLa cells (Fig. 2) 
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Figure 3. Chromatogram of representative CAT assays with extracts from 
transfectant HeLa pRbCAT2-A cells with (50 ng/ml) and without TPA 
treatment. 
pH06Nl, resulted in less CAT activity than that on its 
cotransfection with pHomer 6. In contrast, cotransfection of 
pRbCAT2 with the mutant Η-ras construct pH06Tl, resulted 
in enhanced CAT activity. In two independent experiments, 
we observed an average of 3-fold reduction and 2-fold 
increase in CAT activity with the normal and mutant H-ras, 
respectively. 
TPA increased, whereas EGF had no effect on Rb transcription. 
It was of interest to examine the responsiveness of Rb-1 
promoter to phorbol ester TPA. The possibility that the 
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Figure 4. Chromatogram of representative CAT assays with extracts from 
transfectant HeLa pRbCAT2-A cells with 20 μg/ml (lane 2). 10 μg/ml (lane 3) 
and 5 μg/ml (lane 4) and without (lane 1 ) EGF treatment. 
human Rb-1 promoter could respond to the TPA was 
examined by treating stable transfectants carrying a CAT 
gene linked to the Rb-1 promoter. Transfectant cell line was 
obtained by transfecting plasmid pRbCAT2-A into recipient 
HeLa cells and selecting for geneticin resistance. Treatment 
with TPA was performed at various TPA concentrations and 
time intervals. At optimum conditions, that is, after 12 h 
exposure to 50 ng TPA/ml, CAT expression in HeLa 
RbCAT2-A transfectants which carried CAT plasmid linked 
to the Rb-1 promoter was increased (2.3-fold) compared to 
untreated cells (Fig. 3). On the other hand HeLa cells 
transfected with the same plasmid did not respond to EGF 
(Fig. 4). 
Discussion 
The mechanism by which several transcription factors 
interact with the Rb promoter and trigger RNA synthesis, 
remains unknown. However, it is obvious that an important 
step towards understanding the regulation and function of the 
Rb promoter is the investigation of such interactions. 
In this study we have shown that normal ras suppresses 
Rb transcription in contrast to mutated ras which enhances it. 
To our knowledge suppression or activation of the Rb 
transcription by the normal or the mutated ras gene, 
respectively has not so far been reported. However, it is 
known that mutated ra.v leads to phosphorylation of the p53 
protein through activation of MAP-2 and casein kinase II 
(26). It has also been reported that the wild-type p53 protein 
suppresses the transcription of the Rb gene through a ex­
acting element mapped within the Rb promoter (20). Thus, 
we can suggest that mutated ras enhances the Rb 
transcription via phosphorylation and consequently 
inactivation of the p53 protein. Alternatively, the ras genes 
can influence the Rb transcription through activation of raf-\ 
and MAP-2 kinase which can then activate both S6 kinase 
and DNA synthesis-promoting factor (SPF). SPF contains 
cyclin, ρ 107, the transcription factor E2F and tumor 
suppressors such as the retinoblastoma gene product and p53 
(26). 
It is well known that stimulation of cell growth by TPA 
occurs through its direct interaction with protein kinase C 
(27). Also, it has been reported that TPA can induce 
expression of a CAT gene linked to the human H-ra.s 1 
promoter region (21). We found that TPA activates the 
transcription of Rb gene. This activation may be either a 
direct effect of the TPA on the Rb promoter, possibly 
through a TPA-responsive element or an indirect effect 
through activation of the mutated ras gene and subsequent 
activation of the Rb gene. 
It has been found that many tyrosine kinases including the 
receptors for epidermal growth factor, nerve growth factor 
and insulin transmit intracellular signals through ra.v proteins 
(28-31). Ligand binding to such receptors stimulates ras 
guanine-nucleotide exchange activity (32-36) and increases 
the level of GTP-bound ras (37,38). Whether EGF acts also 
through inhibition of the Rb gene has not been reported. In 
order to investigate this possibility we treated stable clones of 
HeLa cells carrying the Rb promoter with various 
concentrations of EGF. Our results show that EGF has no 
effect on the transcription of the Rb gene. 
In conclusion, our results indicate that the transcription of 
the Rb gene may be regulated through normal and mutated 
ras as well as phorbol esters. Even if the suppression of the 
Rb transcription by normal ras or the activation by its 
mutated form seems to be a paradox, it may reflect an 
additional mechanism through which the cells avoid 
tumorigenesis. 
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